Pyrazinamide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Dava Pharmaceuticals, Inc.. The primary component is Pyrazinamide.
Product ID | 67253-660_6456d188-4ee2-4630-bffc-d41e04d17e53 |
NDC | 67253-660 |
Product Type | Human Prescription Drug |
Proprietary Name | Pyrazinamide |
Generic Name | Pyrazinamide |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 1971-06-03 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA080157 |
Labeler Name | DAVA Pharmaceuticals, Inc. |
Substance Name | PYRAZINAMIDE |
Active Ingredient Strength | 500 mg/1 |
Pharm Classes | Antimycobacterial [EPC] |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 1971-06-03 |
Marketing End Date | 2022-03-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA080157 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1971-06-03 |
Marketing End Date | 2022-03-31 |
Marketing Category | ANDA |
Application Number | ANDA080157 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1971-06-03 |
Marketing End Date | 2022-03-31 |
Ingredient | Strength |
---|---|
PYRAZINAMIDE | 500 mg/1 |
SPL SET ID: | 257bd8cf-74d7-45db-bf25-354a8d26634e |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0904-6696 | Pyrazinamide | Pyrazinamide |
10135-735 | PYRAZINAMIDE | pyrazinamide tablet |
33342-447 | Pyrazinamide | Pyrazinamide |
50090-0520 | Pyrazinamide | Pyrazinamide |
50090-0521 | Pyrazinamide | Pyrazinamide |
50090-5963 | Pyrazinamide | Pyrazinamide |
55695-026 | Pyrazinamide | Pyrazinamide |
60687-138 | Pyrazinamide | Pyrazinamide |
61748-012 | Pyrazinamide | Pyrazinamide |
67253-660 | Pyrazinamide | Pyrazinamide |
70518-0085 | Pyrazinamide | Pyrazinamide |
70518-2534 | Pyrazinamide | Pyrazinamide |
70954-484 | Pyrazinamide | Pyrazinamide |